InvestorsHub Logo

plexrec

01/27/23 9:17 AM

#400211 RE: hnbadger1 #400206

"The hiring of Dr Jin Kun "--for sure--another great move--chug-chug-chug !!!

boi568

01/27/23 10:33 AM

#400238 RE: hnbadger1 #400206

What Kun Jin knows will be more important. If he were the FDA biostatistician in charge of reviewing the submissions for Aduhelm and Leqembi, as has been stated here, he is the perfect person to make the case that blarcamesine is statistically superior to either of them. No one would have better credentials for that role.

rx7171

01/27/23 10:44 AM

#400247 RE: hnbadger1 #400206

Hiring of three FDA veterans to me sends a strong signal that Missling is not holding back expecting to hand over the filing job to partners.

Waiting to partner after filing strong NDA’s will maximize shareholder value.
Bullish
Bullish